|
2014-02-04 |
2014-01-31 |
B
Purchase
|
BAUPOST GROUP LLC/MA
Large shareholder
|
16,420,241
+44.5%
6.50
USD 106,731,567
|
16,420,241
+44.5%
|
6.50
|
USD 106,731,567
|
|
|
2012-03-20 |
2012-03-16 |
S
Sale
|
Fanning Paul
SVP, Human Resources
Officer
|
30,000
-95.8%
11.04
USD 331,200
|
30,000
-95.8%
|
11.04
|
USD 331,200
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
2,133
+0.0%
7.39
USD 15,763
|
2,133
+0.0%
|
7.39
|
USD 15,763
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
493
+0.0%
6.52
USD 3,214
|
493
+0.0%
|
6.52
|
USD 3,214
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
436
+0.0%
5.80
USD 2,529
|
436
+0.0%
|
5.80
|
USD 2,529
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
883
+0.0%
5.79
USD 5,113
|
883
+0.0%
|
5.79
|
USD 5,113
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
7,402
+0.0%
5.46
USD 40,415
|
7,402
+0.0%
|
5.46
|
USD 40,415
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
11,433
+0.0%
5.11
USD 58,423
|
11,433
+0.0%
|
5.11
|
USD 58,423
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
39
+0.0%
5.10
USD 199
|
39
+0.0%
|
5.10
|
USD 199
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
3,093
+0.0%
3.79
USD 11,722
|
3,093
+0.0%
|
3.79
|
USD 11,722
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
4,336
+0.0%
3.17
USD 13,745
|
4,336
+0.0%
|
3.17
|
USD 13,745
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
232
+0.0%
3.04
USD 705
|
232
+0.0%
|
3.04
|
USD 705
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
427
+0.0%
2.97
USD 1,268
|
427
+0.0%
|
2.97
|
USD 1,268
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
8,960
+0.0%
2.96
USD 26,522
|
8,960
+0.0%
|
2.96
|
USD 26,522
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
3,117
+0.0%
2.90
USD 9,039
|
3,117
+0.0%
|
2.90
|
USD 9,039
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
1,321
+0.0%
2.85
USD 3,765
|
1,321
+0.0%
|
2.85
|
USD 3,765
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
997
+0.0%
2.78
USD 2,772
|
997
+0.0%
|
2.78
|
USD 2,772
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
997
+0.0%
2.69
USD 2,682
|
997
+0.0%
|
2.69
|
USD 2,682
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
2,493
+0.0%
2.56
USD 6,382
|
2,493
+0.0%
|
2.56
|
USD 6,382
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
366
+0.0%
2.47
USD 904
|
366
+0.0%
|
2.47
|
USD 904
|
|
|
2012-02-23 |
2012-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
35,735
+0.1%
2.41
USD 86,121
|
35,735
+0.1%
|
2.41
|
USD 86,121
|
|
|
2011-11-22 |
2011-11-22 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
9,197
+0.0%
5.46
USD 50,216
|
9,197
+0.0%
|
5.46
|
USD 50,216
|
|
|
2011-11-22 |
2011-11-22 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
2,107
+0.0%
5.11
USD 10,767
|
2,107
+0.0%
|
5.11
|
USD 10,767
|
|
|
2011-11-22 |
2011-11-22 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
20,228
+0.1%
4.70
USD 95,072
|
20,228
+0.1%
|
4.70
|
USD 95,072
|
|
|
2011-11-22 |
2011-11-22 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
140
+0.0%
3.79
USD 531
|
140
+0.0%
|
3.79
|
USD 531
|
|
|
2011-11-22 |
2011-11-22 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
1,146
+0.0%
3.17
USD 3,633
|
1,146
+0.0%
|
3.17
|
USD 3,633
|
|
|
2011-11-22 |
2011-11-22 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
6,476
+0.0%
2.95
USD 19,104
|
6,476
+0.0%
|
2.95
|
USD 19,104
|
|
|
2011-11-22 |
2011-11-22 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
11,236
+0.0%
2.41
USD 27,079
|
11,236
+0.0%
|
2.41
|
USD 27,079
|
|
|
2011-04-13 |
2011-04-13 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
1,785,714
+5.7%
2.80
USD 4,999,999
|
1,785,714
+5.7%
|
2.80
|
USD 4,999,999
|
|
|
2011-02-25 |
2011-02-25 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
206
+0.0%
5.11
USD 1,053
|
206
+0.0%
|
5.11
|
USD 1,053
|
|
|
2011-02-25 |
2011-02-25 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
1,760
+0.0%
3.88
USD 6,829
|
1,760
+0.0%
|
3.88
|
USD 6,829
|
|
|
2011-02-25 |
2011-02-25 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
860
+0.0%
3.79
USD 3,259
|
860
+0.0%
|
3.79
|
USD 3,259
|
|
|
2011-02-25 |
2011-02-25 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
897
+0.0%
2.96
USD 2,655
|
897
+0.0%
|
2.96
|
USD 2,655
|
|
|
2011-02-25 |
2011-02-25 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
17,270
+0.1%
2.41
USD 41,621
|
17,270
+0.1%
|
2.41
|
USD 41,621
|
|
|
2010-11-26 |
2010-11-26 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
486
+0.0%
5.46
USD 2,654
|
486
+0.0%
|
5.46
|
USD 2,654
|
|
|
2010-11-26 |
2010-11-26 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
1,332
+0.0%
5.11
USD 6,807
|
1,332
+0.0%
|
5.11
|
USD 6,807
|
|
|
2010-11-26 |
2010-11-26 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
165
+0.0%
3.79
USD 625
|
165
+0.0%
|
3.79
|
USD 625
|
|
|
2010-11-26 |
2010-11-26 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
44
+0.0%
2.96
USD 130
|
44
+0.0%
|
2.96
|
USD 130
|
|
|
2010-11-26 |
2010-11-26 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
822
+0.0%
2.64
USD 2,170
|
822
+0.0%
|
2.64
|
USD 2,170
|
|
|
2010-11-26 |
2010-11-26 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
14,234
+0.0%
2.41
USD 34,304
|
14,234
+0.0%
|
2.41
|
USD 34,304
|
|
|
2010-08-23 |
2010-08-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
813
+0.0%
3.79
USD 3,081
|
813
+0.0%
|
3.79
|
USD 3,081
|
|
|
2010-08-23 |
2010-08-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
91
+0.0%
3.04
USD 277
|
91
+0.0%
|
3.04
|
USD 277
|
|
|
2010-08-23 |
2010-08-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
262
+0.0%
2.96
USD 776
|
262
+0.0%
|
2.96
|
USD 776
|
|
|
2010-08-23 |
2010-08-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
36,048
+0.1%
2.41
USD 86,876
|
36,048
+0.1%
|
2.41
|
USD 86,876
|
|
|
2010-06-08 |
2010-06-08 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
1,351
+0.0%
2.41
USD 3,256
|
1,351
+0.0%
|
2.41
|
USD 3,256
|
|
|
2010-02-26 |
2010-02-26 |
B
Purchase
|
NOVARTIS AG
Indirect 10% Owner
|
1,872
+0.0%
2.41
USD 4,512
|
1,872
+0.0%
|
2.41
|
USD 4,512
|
|
|
2009-12-17 |
2009-12-16 |
B
Purchase
|
HODGSON THOMAS R
Non-Executive Director
|
10,387
+22.2%
2.12
USD 22,020
|
10,387
+22.2%
|
2.12
|
USD 22,020
|
|
|
2009-12-17 |
2009-12-15 |
B
Purchase
|
HODGSON THOMAS R
Non-Executive Director
|
15,000
+47.2%
2.15
USD 32,250
|
15,000
+47.2%
|
2.15
|
USD 32,250
|
|
|
2009-12-14 |
2009-12-14 |
B
Purchase
|
HODGSON THOMAS R
Non-Executive Director
|
11,000
+52.9%
2.12
USD 23,320
|
11,000
+52.9%
|
2.12
|
USD 23,320
|
|
|
2009-12-14 |
2009-12-11 |
B
Purchase
|
HODGSON THOMAS R
Non-Executive Director
|
8,613
+70.6%
2.08
USD 17,915
|
8,613
+70.6%
|
2.08
|
USD 17,915
|
|
|
2009-12-14 |
2009-12-10 |
B
Purchase
|
HODGSON THOMAS R
Non-Executive Director
|
5,000
+69.4%
2.05
USD 10,250
|
5,000
+69.4%
|
2.05
|
USD 10,250
|
|
|
2009-11-24 |
2009-11-24 |
B
Purchase
|
Weidenbruch John
Ex. VP, Gen. Counsel and Secr.
Officer
|
20,000
+133.3%
1.89
USD 37,800
|
20,000
+133.3%
|
1.89
|
USD 37,800
|
|
|
2009-08-24 |
2009-08-21 |
B
Purchase
|
NOVARTIS AG
INDIRECT 10% OWNER
|
3,431
+0.0%
2.41
USD 8,269
|
3,431
+0.0%
|
2.41
|
USD 8,269
|
|
|
2009-05-29 |
2009-05-29 |
B
Purchase
|
NOVARTIS AG
INDIRECT 10% OWNER
|
2,451
+0.0%
2.62
USD 6,422
|
2,451
+0.0%
|
2.62
|
USD 6,422
|
|
|
2009-02-23 |
2009-02-23 |
B
Purchase
|
NOVARTIS AG
Indirect 10% owner
|
5,444
+0.0%
2.41
USD 13,120
|
5,444
+0.0%
|
2.41
|
USD 13,120
|
|
|
2008-11-25 |
2008-11-19 |
B
Purchase
|
NOVARTIS AG
INDIRECT 10% OWNER
|
4,747
+0.0%
4.05
USD 19,225
|
4,747
+0.0%
|
4.05
|
USD 19,225
|
|
|
2008-09-03 |
2008-09-02 |
B
Purchase
|
NOVARTIS AG
Large shareholder
|
4,654
+0.0%
2.93
USD 13,636
|
4,654
+0.0%
|
2.93
|
USD 13,636
|
|
|
2008-05-30 |
2008-05-29 |
B
Purchase
|
NOVARTIS AG
Large shareholder
|
924
+0.0%
2.41
USD 2,227
|
924
+0.0%
|
2.41
|
USD 2,227
|
|
|
2008-03-13 |
2008-03-11 |
B
Purchase
|
Mayers Douglas L
EVP and Chief Medical Officer
Officer
|
30,000
+inf%
4.45
USD 133,500
|
30,000
+inf%
|
4.45
|
USD 133,500
|
|
|
2007-07-19 |
2007-07-13 |
B
Purchase
|
Koppy Susan
Sr. VP, Business and Corp Dev.
Officer
|
400
+160.0%
3.84
USD 1,536
|
400
+160.0%
|
3.84
|
USD 1,536
|
|
|
2006-06-08 |
2006-06-06 |
B
Purchase
|
NOVARTIS AG
Large shareholder
|
365
+0.0%
20.48
USD 7,475
|
365
+0.0%
|
20.48
|
USD 7,475
|
|
|
2006-05-11 |
2006-05-09 |
B
Purchase
|
Sommadossi Jean-Pierre
President, CEO, Chairman
Executive Director
|
10,000
+0.5%
9.13
USD 91,300
|
10,000
+0.5%
|
9.13
|
USD 91,300
|
|
|
2006-05-10 |
2006-05-08 |
B
Purchase
|
Koppy Susan
Sr. VP, Business and Corp Dev.
Officer
|
200
+400.0%
9.26
USD 1,852
|
200
+400.0%
|
9.26
|
USD 1,852
|
|
|
2006-04-06 |
2006-04-04 |
B
Purchase
|
NOVARTIS AG
Large shareholder
|
2,938
+0.0%
16.23
USD 47,684
|
2,938
+0.0%
|
16.23
|
USD 47,684
|
|
|
2005-11-16 |
2005-11-14 |
S
Sale
|
Pollard-Knight Denise
Non-Executive Director
|
629,498
-67.6%
20.61
USD 12,973,954
|
629,498
-67.6%
|
20.61
|
USD 12,973,954
|
|
|
2005-11-02 |
2005-10-31 |
B
Purchase
|
NOVARTIS AG
Large shareholder
|
3,939,131
+14.4%
20.61
USD 81,185,490
|
3,939,131
+14.4%
|
20.61
|
USD 81,185,490
|
|
|
2004-07-29 |
2004-07-27 |
B
Purchase
|
HODGSON THOMAS R
|
7,200
+20.5%
14.00
USD 100,800
|
7,200
+20.5%
|
14.00
|
USD 100,800
|
|
|
2004-07-29 |
2004-07-27 |
B
Purchase
|
Corcoran Andrea
Exec. VP, Legal and Admin.
|
7,200
+12.8%
14.00
USD 100,800
|
7,200
+12.8%
|
14.00
|
USD 100,800
|
|
|
2004-07-29 |
2004-07-27 |
B
Purchase
|
Sommadossi Jean-Pierre
President, CEO, Chairman
Executive Director
|
6,364
+0.3%
14.00
USD 89,096
|
6,364
+0.3%
|
14.00
|
USD 89,096
|
|
|
2004-07-29 |
2004-07-27 |
B
Purchase
|
Macdonald Guy
Executive VP, Operations
|
10,000
+inf%
14.00
USD 140,000
|
10,000
+inf%
|
14.00
|
USD 140,000
|
|
|
2004-07-29 |
2004-07-27 |
B
Purchase
|
Arkowitz David
Chief Financial Officer
|
8,000
+inf%
14.00
USD 112,000
|
8,000
+inf%
|
14.00
|
USD 112,000
|
|
|
2004-07-29 |
2004-07-27 |
B
Purchase
|
BARSHEFSKY CHARLENE
|
20,000
+inf%
14.00
USD 280,000
|
20,000
+inf%
|
14.00
|
USD 280,000
|
|
|
2004-07-29 |
2004-07-27 |
B
Purchase
|
CRAMB CHARLES W JR
|
7,200
+inf%
14.00
USD 100,800
|
7,200
+inf%
|
14.00
|
USD 100,800
|
|
|
2004-07-29 |
2004-07-27 |
B
Purchase
|
Egan James
Sr. VP, Business and Corp Dev
|
13,400
+6.2%
14.00
USD 187,600
|
13,400
+6.2%
|
14.00
|
USD 187,600
|
|
|
2004-07-28 |
2004-07-27 |
S
Sale
|
GADICKE ANSBERT
Large shareholder
|
508,371
-9.6%
14.00
USD 7,117,194
|
508,371
-9.6%
|
14.00
|
USD 7,117,194
|
|
